Potential Roles of mtDNA Mutations in PCOS-IR: A Review

References

• Swaroop A, Jaipuriar AS, Gupta SK, et al. Efficacy of a novel fenugreek seed extract (Trigonella foenum-graecum, Furocyst) in polycystic ovary syndrome (PCOS). Int J Med Sci. 2015;12(10):825–831. doi:10.7150/ijms.13024
   PubMed Web of Science ®Google Scholar
• Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8:41. doi:10.1186/1741-7015-8-41
   PubMed Web of Science ®Google Scholar
• Azziz R, Carmina E, Dewailly D, et al.; Androgen Excess Society. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91(11):4237–4245. doi:10.1210/jc.2006-0178
   PubMed Web of Science ®Google Scholar
• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004
   Web of Science ®Google Scholar
• Conway G, Dewailly D, Diamanti-Kandarakis E, et al.; ESE PCOS Special Interest Group. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology. Eur J Endocrinol. 2014;171(4):P1–29. doi:10.1530/EJE-14-0253
   PubMed Web of Science ®Google Scholar
• Dokras A, Saini S, Gibson-Helm M, et al. Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome. Fertil Steril. 2017;107(6):1380–1386.e1. doi:10.1016/j.fertnstert.2017.04.011
   PubMed Web of Science ®Google Scholar
• Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855. doi:10.1093/humrep/dew218
   PubMed Web of Science ®Google Scholar
• Khan MJ, Ullah A, Basit S. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives. Appl Clin Genet. 2019;12:249–260. doi:10.2147/TACG.S200341
   PubMed Web of Science ®Google Scholar
• Nidhi R, Padmalatha V, Nagarathna R, et al. Prevalence of polycystic ovarian syndrome in Indian adolescents. J Pediatr Adolesc Gynecol. 2011;24(4):223–227. doi:10.1016/j.jpag.2011.03.002
   PubMed Web of Science ®Google Scholar
• McGowan MP. Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. Curr Treat Options Cardiovasc Med. 2011;13(4):289–301. doi:10.1007/s11936-011-0130-0
   PubMedGoogle Scholar
• Lizneva D, Suturina L, Walker W, et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106(1):6–15. doi:10.1016/j.fertnstert.2016.05.003
   PubMed Web of Science ®Google Scholar
• Zhang C, Ma J, Wang W, et al. Lysyl oxidase blockade ameliorates anovulation in polycystic ovary syndrome. Hum Reprod. 2018;33(11):2096–2106. doi:10.1093/humrep/dey292
   PubMed Web of Science ®Google Scholar
• Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: what’s new? Adv Clin Exp Med. 2017;26(2):359–367. doi:10.17219/acem/59380
   PubMed Web of Science ®Google Scholar
• Teede HJ, Hutchison SK, Zoungas S. The management of insulin resistance in polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18(7):273–279. doi:10.1016/j.tem.2007.08.001
   PubMed Web of Science ®Google Scholar
• Mastrototaro L, Roden M. Insulin resistance and insulin sensitizing agents. Metabolism. 2021;125:154892. doi:10.1016/j.metabol.2021.154892
   PubMed Web of Science ®Google Scholar
• Vecchio I, Tornali C, Bragazzi NL, et al. The discovery of insulin: an important milestone in the history of medicine. Front Endocrinol. 2018;9:613. doi:10.3389/fendo.2018.00613
   PubMed Web of Science ®Google Scholar
• Tsatsoulis A, Mantzaris MD, Bellou S, et al. Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment-an evolutionary perspective. Metabolism. 2013;62(5):622–633. doi:10.1016/j.metabol.2012.11.004
   PubMed Web of Science ®Google Scholar
• Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS. Arch Physiol Biochem. 2020;126(2):183–186. doi:10.1080/13813455.2018.1499120
   PubMed Web of Science ®Google Scholar
• He FF, Li YM. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73. doi:10.1186/s13048-020-00670-3
   PubMed Web of Science ®Google Scholar
• Docea AO, Vassilopoulou L, Fragou D, et al. CYP polymorphisms and pathological conditions related to chronic exposure to organochlorine pesticides. Toxicol Rep. 2017;4:335–341. doi:10.1016/j.toxrep.2017.05.007
   PubMedGoogle Scholar
• Rothenberg SS, Beverley R, Barnard E, et al. Polycystic ovary syndrome in adolescents. Best Pract Res Clin Obstet Gynaecol. 2018;48:103–114. doi:10.1016/j.bpobgyn.2017.08.008
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520. doi:10.1210/er.2015-1104
   PubMed Web of Science ®Google Scholar
• Cassar S, Misso ML, Hopkins WG, et al. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619–2631. doi:10.1093/humrep/dew243
   PubMed Web of Science ®Google Scholar
• Condorelli RA, Calogero AE, Di Mauro M, et al. PCOS and diabetes mellitus: from insulin resistance to altered beta pancreatic function, a link in evolution. Gynecol Endocrinol. 2017;33(9):665–667. doi:10.1080/09513590.2017.1342240
   PubMed Web of Science ®Google Scholar
• Pandurevic S, Macut D, Fanelli F, et al. Biomediators in polycystic ovary syndrome and cardiovascular risk. Biomolecules. 2021;11(9):1350. doi:10.3390/biom11091350
   PubMed Web of Science ®Google Scholar
• Hernansanz-Agustín P, Enríquez JA. Inner mitochondrial membrane sensitivity to Na+ reveals partially segmented functional CoQ pools. J Vis Exp. 2022;2022(185):1. doi:10.3791/63729
   Google Scholar
• Kang PT, Chen CL, Lin P, et al. Mitochondrial complex I in the post-ischemic heart: reperfusion-mediated oxidative injury and protein cysteine sulfonation. J Mol Cell Cardiol. 2018;121:190–204. doi:10.1016/j.yjmcc.2018.07.244
   PubMed Web of Science ®Google Scholar
• Ackrell BA. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 2000;466(1):1–5. doi:10.1016/s0014-5793(99)01749-4
   PubMed Web of Science ®Google Scholar
• Cecchini G. Function and structure of complex II of the respiratory chain. Annu Rev Biochem. 2003;72:77–109. doi:10.1146/annurev.biochem.72.121801.161700
   PubMed Web of Science ®Google Scholar
• Klimova T, Chandel NS. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 2008;15(4):660–666. doi:10.1038/sj.cdd.4402307
   PubMed Web of Science ®Google Scholar
• Chandel NS. Mitochondrial complex III: an essential component of universal oxygen sensing machinery? Respir Physiol Neurobiol. 2010;174(3):175–181. doi:10.1016/j.resp.2010.08.004
   PubMed Web of Science ®Google Scholar
• Starkov AA. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann N Y Acad Sci. 2008;1147:37–52. doi:10.1196/annals.1427.015
   PubMed Web of Science ®Google Scholar
• Wallace DC. A mitochondrial bioenergetic etiology of disease. J Clin Invest. 2013;123(4):1405–1412. doi:10.1172/JCI61398
   PubMed Web of Science ®Google Scholar
• Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a Dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407. doi:10.1146/annurev.genet.39.110304.095751
   PubMed Web of Science ®Google Scholar
• Kang E, Wu J, Gutierrez NM, et al. Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations. Nature. 2016;540(7632):270–275. doi:10.1038/nature20592
   PubMed Web of Science ®Google Scholar
• Grandhi S, Bosworth C, Maddox W, et al. Heteroplasmic shifts in tumor mitochondrial genomes reveal tissue-specific signals of relaxed and positive selection. Hum Mol Genet. 2017;26(15):2912–2922. doi:10.1093/hmg/ddx172
   PubMed Web of Science ®Google Scholar
• Stewart JB, Chinnery PF. Extreme heterogeneity of human mitochondrial DNA from organelles to populations. Nat Rev Genet. 2021;22(2):106–118. doi:10.1038/s41576-020-00284-x
   PubMed Web of Science ®Google Scholar
• Rossignol R, Faustin B, Rocher C, et al. Mitochondrial threshold effects. Biochem J. 2003;370(Pt 3):751–762. doi:10.1042/BJ20021594
   PubMedGoogle Scholar
• Luo L, Gu F, Jie H, et al. Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer - a matched-pair study. Reprod Biomed Online. 2017;35(5):576–582. doi:10.1016/j.rbmo.2017.07.010
   PubMed Web of Science ®Google Scholar
• Macut D, Bjekić-Macut J, Savić-Radojević A. Dyslipidemia and oxidative stress in PCOS. Front Horm Res. 2013;40:51–63. doi:10.1159/000341683
   PubMed Web of Science ®Google Scholar
• Chenna S, Koopman WJH, Prehn JHM, et al. Mechanisms and mathematical modeling of ROS production by the mitochondrial electron transport chain. Am J Physiol Cell Physiol. 2022;323(1):C69–C83. doi:10.1152/ajpcell.00455.2021
   PubMed Web of Science ®Google Scholar
• Shan H, Luo R, Guo X, et al. Abnormal endometrial receptivity and oxidative stress in polycystic ovary syndrome. Front Pharmacol. 2022;13:904942. doi:10.3389/fphar.2022.904942
   PubMed Web of Science ®Google Scholar
• Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944–948. doi:10.1038/nature04634
   PubMed Web of Science ®Google Scholar
• Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005;7(7–8):1040–1052. doi:10.1089/ars.2005.7.1040
   PubMed Web of Science ®Google Scholar
• Ma J, Nakagawa Y, Kojima I, et al. Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes. J Biol Chem. 2014;289(1):133–142. doi:10.1074/jbc.M113.533240
   PubMed Web of Science ®Google Scholar
• Zhuo G, Ding Y, Feng G, et al. Analysis of mitochondrial DNA sequence variants in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2012;286(3):653–659. doi:10.1007/s00404-012-2358-7
   PubMed Web of Science ®Google Scholar
• Zhu J, Vinothkumar KR, Hirst J. Structure of mammalian respiratory complex I. Nature. 2016;536(7616):354–358. doi:10.1038/nature19095
   PubMed Web of Science ®Google Scholar
• Ji Y, Zhang J, Yu J, et al. Contribution of mitochondrial ND1 3394T>C mutation to the phenotypic manifestation of Leber’s hereditary optic neuropathy. Hum Mol Genet. 2019;28(9):1515–1529. doi:10.1093/hmg/ddy450
   PubMed Web of Science ®Google Scholar
• Kokaze A, Ishikawa M, Matsunaga N, et al. Longevity-associated mitochondrial DNA 5178 A/C polymorphism and blood pressure in the Japanese population. J Hum Hypertens. 2004;18(1):41–45. doi:10.1038/sj.jhh.1001632
   PubMed Web of Science ®Google Scholar
• Mukae S, Aoki S, Itoh S, et al. Mitochondrial 5178A/C genotype is associated with acute myocardial infarction. Circ J. 2003;67(1):16–20. doi:10.1253/circj.67.16
   PubMed Web of Science ®Google Scholar
• Jiang Z, Teng L, Zhang S, et al. Mitochondrial ND1 T4216C and ND2 C5178A mutations are associated with maternally transmitted diabetes mellitus. Mitochondrial DNA a DNA Mapp Seq Anal. 2021;32(2):59–65. doi:10.1080/24701394.2020.1856101
   PubMedGoogle Scholar
• Ding Y, Zhuo G, Zhang C, et al. Point mutation in mitochondrial tRNA gene is associated with polycystic ovary syndrome and insulin resistance. Mol Med Rep. 2016;13(4):3169–3172. doi:10.3892/mmr.2016.4916
   PubMed Web of Science ®Google Scholar
• Jiang Z, Cai X, Kong J, et al. Maternally transmitted diabetes mellitus may be associated with mitochondrial ND5 T12338C and tRNAAla T5587C variants. Ir J Med Sci. 2022;191(6):2625–2633. doi:10.1007/s11845-021-02911-w
   PubMed Web of Science ®Google Scholar
• Zhang J, Ji Y, Lu Y, et al. Leber’s hereditary optic neuropathy (LHON)-associated ND5 12338T > C mutation altered the assembly and function of complex I, apoptosis and mitophagy. Hum Mol Genet. 2018;27(11):1999–2011. doi:10.1093/hmg/ddy107
   PubMed Web of Science ®Google Scholar
• Cai W, Fu Q, Zhou X, et al. Mitochondrial variants may influence the phenotypic manifestation of Leber’s hereditary optic neuropathy-associated ND4 G11778A mutation. J Genet Genomics. 2008;35(11):649–655. doi:10.1016/S1673-8527(08)60086-7
   PubMed Web of Science ®Google Scholar
• Bi R, Zhang AM, Jia X, et al. Complete mitochondrial DNA genome sequence variation of Chinese families with mutation m.3635G>A and Leber hereditary optic neuropathy. Mol Vis. 2012;18:3087–3094.
   PubMed Web of Science ®Google Scholar
• Huoponen K, Lamminen T, Juvonen V, et al. The spectrum of mitochondrial DNA mutations in families with Leber hereditary optic neuroretinopathy. Hum Genet. 1993;92(4):379–384. doi:10.1007/BF01247339
   PubMed Web of Science ®Google Scholar
• Nicholls TJ, Minczuk M. In D-loop: 40 years of mitochondrial 7S DNA. Exp Gerontol. 2014;56:175–181. doi:10.1016/j.exger.2014.03.027
   PubMed Web of Science ®Google Scholar
• Deng X, Ji D, Li X, et al. Polymorphisms and haplotype of mitochondrial DNA D-loop region are associated with polycystic ovary syndrome in a Chinese population. Mitochondrion. 2021;57:173–181. doi:10.1016/j.mito.2020.12.006
   PubMed Web of Science ®Google Scholar
• Máximo V, Soares P, Lima J, et al. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors. Am J Pathol. 2002;160(5):1857–1865. doi:10.1016/S0002-9440(10)61132-7
   PubMed Web of Science ®Google Scholar
• Li X, Ji D, Marley JL, et al. Association between mitochondrial DNA D-loop region polymorphisms and endometriosis in a Chinese population. J Assist Reprod Genet. 2020;37(9):2171–2179. doi:10.1007/s10815-020-01853-z
   PubMed Web of Science ®Google Scholar
• Yusoff AAM, Abdullah WSW, Khair SZNM, et al. A comprehensive overview of mitochondrial DNA 4977-bp deletion in cancer studies. Oncol Rev. 2019;13(1):409. doi:10.4081/oncol.2019.409
   PubMed Web of Science ®Google Scholar
• Ye M, Hu B, Shi W, et al. Mitochondrial DNA 4977 bp deletion in peripheral blood is associated with polycystic ovary syndrome. Front Endocrinol. 2021;12:675581. doi:10.3389/fendo.2021.675581
   PubMed Web of Science ®Google Scholar
• Wei YH, Lee CF, Lee HC, et al. Increases of mitochondrial mass and mitochondrial genome in association with enhanced oxidative stress in human cells harboring 4977 BP-deleted mitochondrial DNA. Ann N Y Acad Sci. 2001;928:97–112. doi:10.1111/j.1749-6632.2001.tb05640.x
   PubMed Web of Science ®Google Scholar
• Ding Y, Zhuo G, Zhang C. The mitochondrial tRNALeu(UUR) A3302G mutation may be associated with insulin resistance in woman with polycystic ovary syndrome. Reprod Sci. 2016;23(2):228–233. doi:10.1177/1933719115602777
   PubMed Web of Science ®Google Scholar
• Hutchison WM, Thyagarajan D, Poulton J, et al. Clinical and molecular features of encephalomyopathy due to the A3302G mutation in the mitochondrial tRNA(Leu(UUR)) gene. Arch Neurol. 2005;62(12):1920–1923. doi:10.1001/archneur.62.12.1920
   PubMedGoogle Scholar
• Maniura-Weber K, Helm M, Engemann K, et al. Molecular dysfunction associated with the human mitochondrial 3302A>G mutation in the MTTL1 (mt-tRNALeu(UUR)) gene. Nucleic Acids Res. 2006;34:6404–6415. doi:10.1093/nar/gkl727
   PubMed Web of Science ®Google Scholar
• Bindoff LA, Howell N, Poulton J, et al. Abnormal RNA processing associated with a novel tRNA mutation in mitochondrial DNA. A potential disease mechanism. J Biol Chem. 1993;268(26):19559–19564. doi:10.1016/S0021-9258(19)36552-4
   PubMed Web of Science ®Google Scholar
• Ding Y, Xia BH, Zhang CJ, et al. Mitochondrial tRNALeu(UUR) C3275T, tRNAGln T4363C and tRNALys A8343G mutations may be associated with PCOS and metabolic syndrome. Gene. 2018;642:299–306. doi:10.1016/j.gene.2017.11.049
   PubMed Web of Science ®Google Scholar
• Garcia-Lozano JR, Aguilera I, Bautista J, et al. A new mitochondrial DNA mutation in the tRNA leucine 1 gene (C3275A) in a patient with Leber’s hereditary optic neuropathy. Hum Mutat. 2000;15(1):120–121. doi:10.1002/(SICI)1098-1004(200001)15:1<120::AID-HUMU33>3.0.CO;2-8
   PubMedGoogle Scholar
• Ding Y, Xia BH, Zhang CJ, et al. Mutations in mitochondrial tRNA genes may be related to insulin resistance in women with polycystic ovary syndrome. Am J Transl Res. 2017;9(6):2984–2996.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Nagao A, Suzuki T. Human mitochondrial tRNAs: biogenesis, function, structural aspects, and diseases. Annu Rev Genet. 2011;45:299–329. doi:10.1146/annurev-genet-110410-132531
   PubMed Web of Science ®Google Scholar
• Wang L, Dong Z, Lin W, et al. Molecular characterization of a pedigree carrying the hypertension‑associated mitochondrial tRNAGln T4363C mutation. Mol Med Rep. 2017;16(5):6029–6033. doi:10.3892/mmr.2017.7371
   PubMed Web of Science ®Google Scholar
• Zhu H-Y, Wang S-W, Liu L, et al. Genetic variants in mitochondrial tRNA genes are associated with essential hypertension in a Chinese Han population. Clin Chim Acta. 2009;410(1–2):64–69. doi:10.1016/j.cca.2009.09.023
   PubMed Web of Science ®Google Scholar
• Ozawa T, Tanaka M, Sugiyama S, et al. Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson’s disease and mitochondrial encephalomyopathy. Biochem Biophys Res Commun. 1991;177(1):518–525. doi:10.1016/0006-291x(91)92014-b
   PubMed Web of Science ®Google Scholar
• Lu J, Qian Y, Li Z, et al. Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation. Mitochondrion. 2010;10(1):69–81. doi:10.1016/j.mito.2009.09.007
   PubMed Web of Science ®Google Scholar
• Sprinzl M, Horn C, Brown M, et al. Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res. 1998;26(1):148–153. doi:10.1093/nar/26.1.148
   PubMed Web of Science ®Google Scholar
• Peng W, Zhong Y, Zhao X, et al. Low penetrance of hearing loss in two Chinese families carrying the mitochondrial tRNASer(UCN) mutations. Mol Med Rep. 2020;22(1):77–86. doi:10.3892/mmr.2020.11100
   PubMed Web of Science ®Google Scholar
• Silvestri G, Servidei S, Rana M, et al. A novel mitochondrial DNA point mutation in the tRNA(Ile) gene is associated with progressive external ophtalmoplegia. Biochem Biophys Res Commun. 1996;220(3):623–627. doi:10.1006/bbrc.1996.0453
   PubMed Web of Science ®Google Scholar
• Suzuki T, Suzuki T, Wada T, et al. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 2002;21(23):6581–6589. doi:10.1093/emboj/cdf656
   PubMed Web of Science ®Google Scholar
• Najarian D, Shu HH, Martin NC. Sequence and expression of four mutant aspartic acid tRNA genes from the mitochondria of Saccharomyces cerevisiae. Nucleic Acids Res. 1986;14(24):9561–9578. doi:10.1093/nar/14.24.9561
   PubMed Web of Science ®Google Scholar
• Shtilbans A, El-Schahawi M, Malkin E, et al. A novel mutation in the mitochondrial DNA transfer ribonucleic acidAsp gene in a child with myoclonic epilepsy and psychomotor regression. J Child Neurol. 1999;14(9):610–613. doi:10.1177/088307389901400910
   PubMed Web of Science ®Google Scholar
• Delaunay S, Pascual G, Feng B, et al. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. Nature. 2022;607(7919):593–603. doi:10.1038/s41586-022-04898-5
   PubMed Web of Science ®Google Scholar
• Rinaldi T, Lande R, Bolotin-Fukuhara M, et al. Additional copies of the mitochondrial Ef-Tu and aspartyl-tRNA synthetase genes can compensate for a mutation affecting the maturation of the mitochondrial tRNAAsp. Curr Genet. 1997;31(6):494–496. doi:10.1007/s002940050235
   PubMed Web of Science ®Google Scholar
• Belostotsky R, Frishberg Y, Entelis N. Human mitochondrial tRNA quality control in health and disease: a channelling mechanism? RNA Biol. 2012;9(1):33–39. doi:10.4161/rna.9.1.18009
   PubMed Web of Science ®Google Scholar
• Ding Y, Li Y, You J, et al. Mitochondrial tRNA(Glu) A14693G variant may modulate the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation in a Han Chinese family. J Genet Genomics. 2009;36(4):241–250. doi:10.1016/S1673-8527(08)60111-3
   PubMed Web of Science ®Google Scholar
• Wiedemann N, Pfanner N. Mitochondrial machineries for protein import and assembly. Annu Rev Biochem. 2017;86:685–714. doi:10.1146/annurev-biochem-060815-014352
   PubMed Web of Science ®Google Scholar
• Boyapati RK, Dorward DA, Tamborska A, et al. Mitochondrial DNA is a pro-inflammatory damage-associated molecular pattern released during active IBD. Inflamm Bowel Dis. 2018;24(10):2113–2122. doi:10.1093/ibd/izy095
   PubMed Web of Science ®Google Scholar